Hepatitis B Topics HBV Populations Pregnancy & HBV MTCT
AASLD 2015: Tenofovir During Pregnancy Reduces Risk of Mother-to-Child Hepatitis B Transmission
- Details
- Category: Pregnancy & HBV MTCT
- Published on Thursday, 19 November 2015 00:00
- Written by Liz Highleyman
Women with chronic hepatitis B and high viral load who were treated with tenofovir (Viread) during pregnancy were significantly less likely to transmit hepatitis B virus (HBV) to their babies, according to study findings presented this week at the AASLD Liver Meeting in San Francisco. Another study showed that women with hepatitis B often experience viral load or ALT "flares" during pregnancy or post-partum.
Screening and Post-Natal Prophylaxis Reduce Mother-to-Child HBV Transmission
- Details
- Category: Pregnancy & HBV MTCT
- Published on Wednesday, 11 June 2014 00:00
- Written by Liz Highleyman
Prenatal screening of pregnant women for hepatitis B virus (HBV), followed by immune prophylaxis for infants using injected hepatitis B antibodies and the first dose of the HBV vaccine given soon after delivery, resulted in a low rate of vertical HBV transmission -- less than 1 per 100 births -- in a real-world study described in the May 27 advance edition of Annals of Internal Medicine.
IDWeek 2013: Tenofovir May Help Prevent Mother-to-child Hepatitis B Transmission
- Details
- Category: HBV Prevention
- Published on Tuesday, 08 October 2013 00:00
- Written by Liz Highleyman
Taking tenofovir (Viread) during the final months of pregnancy may provide extra protection against perinatal transmission of hepatitis B virus (HBV), along with immunization of the infant, according to a late-breaker presentation the Second IDWeek conference last week in San Francisco.
EASL 2014: Sci-B-Vac Bests Engerix-B for Preventing Mother-to-Child HBV Transmission
- Details
- Category: HBV Vaccines
- Published on Tuesday, 29 April 2014 00:00
- Written by Liz Highleyman
An investigational vaccine known as Sci-B-Vac given to babies born to women with hepatitis B was more effective at preventing HBV infection than the widely used Engerix-B vaccine, according to a report at the EASL International Liver Congress this month in London.
Registry Data Show Hepatitis B Medications Appear Safe during Pregnancy
- Details
- Category: HBV Treatment
- Published on Tuesday, 30 October 2012 00:00
- Written by Liz Highleyman
An analysis of data from the Antiretroviral Pregnancy Registry found no evidence that pregnant women's use of drugs to treat chronic hepatitis B -- including lamivudine (Epivir) and tenofovir (Viread) -- is associated with birth defects, according to a report in the November 2012 Journal of Hepatology. 
More Articles...
- ICAAC 2012: Switching to Tenofovir in ART Regimen Suppresses Hepatitis B in HIV/HBV Coinfected
- ICAAC 2012: Hepatitis B Vaccine Effective Long-term, but Some Lose Protection after 15 Years
- Hepatitis B Rates Higher than Expected among Gay Men, Drug Users, Vaccinated Babies
- Mothers with Hepatitis B Can Safely Breastfeed
- Telbivudine and Elective Cesarean Section Help Prevent Mother-to-child Hepatitis B Transmission
- High HBV Viral Load and HBeAg Positive Status Increase Risk of Mother-to-child Hepatitis B Transmission Despite Vaccine
- Many U.S. Babies Do Not Receive Recommended Therapy to Prevent Hepatitis B Infection
Web Design and Development by